1. Home
  2. EXAS vs CPB Comparison

EXAS vs CPB Comparison

Compare EXAS & CPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Exact Sciences Corporation

EXAS

Exact Sciences Corporation

HOLD

Current Price

$101.58

Market Cap

11.0B

Sector

Health Care

ML Signal

HOLD

Logo Campbell Soup Company

CPB

Campbell Soup Company

HOLD

Current Price

$28.83

Market Cap

9.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXAS
CPB
Founded
1995
1869
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Packaged Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
11.0B
9.4B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
EXAS
CPB
Price
$101.58
$28.83
Analyst Decision
Buy
Hold
Analyst Count
20
16
Target Price
$77.94
$32.38
AVG Volume (30 Days)
10.8M
7.1M
Earning Date
11-03-2025
12-09-2025
Dividend Yield
N/A
5.43%
EPS Growth
N/A
5.83
EPS
N/A
1.94
Revenue
$3,082,033,000.00
$10,158,000,000.00
Revenue This Year
$19.40
N/A
Revenue Next Year
$13.51
$1.11
P/E Ratio
N/A
$14.82
Revenue Growth
14.47
2.71
52 Week Low
$38.81
$27.85
52 Week High
$101.95
$43.85

Technical Indicators

Market Signals
Indicator
EXAS
CPB
Relative Strength Index (RSI) 89.65 38.82
Support Level $100.95 $27.85
Resistance Level $101.95 $29.11
Average True Range (ATR) 0.35 0.83
MACD -0.87 -0.19
Stochastic Oscillator 61.17 23.88

Price Performance

Historical Comparison
EXAS
CPB

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

About CPB Campbell Soup Company

Over the past 150-plus years, Campbell's has evolved into a leading domestic packaged food manufacturer, with a portfolio that extends beyond its iconic red-and-white labeled canned soup. In fiscal 2025 (July year-end), snacks accounted for 43% of its revenue, followed by soup (27%), other simple meals (23%), and beverages (7%). Outside its namesake, its brands include Pepperidge Farm, Goldfish, Snyder's of Hanover, Swanson, Pacific Foods, Prego, Pace, V8, and recently acquired Rao's (a deal that closed in 2024). Around 90% of its revenue results from the US and the remainder from Canada and Latin America.

Share on Social Networks: